Aug. 3 at 1:09 AM
$OPK ITS WORTHLESS ! We owned 1,260,000 shares of Zebra’s Series A-2 Preferred Stock and 900,000 shares of Zebra restricted common stock (ownership 29%) at June 30, 2026 and
December 31, 2025. Zebra is a privately held biotechnology company focused on the discovery and development of biosuperior antibody therapeutics and complex drugs.
Dr. Richard Lerner, M.D., a former member of our Board of Directors, was a founder of Zebra. Dr. Frost serves as a member of Zebra’s Board of Directors.
THIS IS WHAT YOU READ WHEN YOU LOOK UP ZEBRA !
The firm's status is currently listed as archived, with operations concluding in the late 2010s
